Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Corline Biomedical AB
CLBIOCurrent price
8.1 SEK
-0.28 SEK (-3.34%)
Last closed
8.38 SEK
Company
www.corline.se
ISIN
SE0006887451
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
179 196 586 SEK
Yield for 12 month
-51.35 %
1Y
3Y
5Y
10Y
15Y
CLBIO
Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; and CHC, which is used for the treatment of soft tissue injuries. The company was incorporated in 1991 and is based in Uppsala, Sweden. Address: Lefflersgatan 5, Uppsala, Sweden, 754 50
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
356.44 SEKP/E ratio
–Dividend Yield
–Current Year
+24 905 422 SEK
Last Year
+23 432 796 SEK
Current Quarter
+2 243 773 SEK
Last Quarter
+3 719 394 SEK
Current Year
-456 719 SEK
Last Year
+22 612 888 SEK
Current Quarter
-4 375 116 SEK
Last Quarter
-1 697 508 SEK
Key Figures CLBIO
1 year
3 years
5 years
10 years
EBITDA
-6 311 427 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-3.97 %
PEG Ratio
–
Return On Equity TTM
-7.13 %
Wall Street Target Price
356.44 SEK
Revenue TTM
28 680 543 SEK
Book Value
4.05 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-24.1 %
Dividend Yield
–
Gross Profit TTM
22 612 893 SEK
Earnings per share
-0.04 SEK
Diluted Eps TTM
-0.04 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-90.7 %
Profit Margin
-22.41 %
Dividend Analytics CLBIO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CLBIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1196:1163
Payout Ratio
–
Last Split Date
04.01.2021
Dividend Date
–
Stock Valuation CLBIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.5879
Price Sales TTM
6.248
Enterprise Value EBITDA
-315.7946
Price Book MRQ
2.1809
Financials CLBIO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CLBIO
For 52 weeks
7.48 SEK
17.51 SEK
50 Day MA
11.37 SEK
Shares Short Prior Month
–
200 Day MA
12.38 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart